Research
https://journals.lww.com/co-neurology/Abstract/2011/04000/Autoimmune_epilepsies.10.aspx
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2245881/
https://onlinelibrary.wiley.com/doi/abs/10.1002/ana.22307
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430743/
https://www.thieme-connect.com/DOI/DOI?10.1055/s-0031-1277985
A study done at Texas Children’s Hospital looked at the use of Rituximab for young people and its short- or long-term adverse events, infections, or recovery time of B lymphocyte subset counts and immunoglobulin levels. The study led by Dr. McAtee involved patients younger than 21 years receiving Rituximab for more than 25 indications, including […]
The AE Alliance is pleased to announce its inauguration of the AEA Community 2021 Seed Grant Program to support research focused on the diagnosis, management, and outcomes of individuals with AE. We will be awarding multiple grants of $10,000 in 2021. As the name implies, this program is a true community effort. In May 2020 […]
We had the pleasure of having psychiatrist Stephen Rush, MD discuss the role of psychiatry in AE at our recent Midwest Support Group meeting. Dr. Rush is an Associate professor of Psychiatry and the Medical Director of Ambulatory Services at the University of Cincinnati Department of Psychiatry and Behavioral Neuroscience. In his practice he not […]
Vitamin D (cholecalciferol) is a nutrient found in some foods like fatty fish that can be added to your diet as a supplement. Our body makes vitamin D when our skin is directly exposed to the sun, and most people meet at least some of their vitamin D needs this way. Vitamin D is required […]
Dr. Pojen Deng and Dr. Anusha Yeshokumar (Mount Sinai Health System) discuss autoimmune encephalitis and a multidisciplinary approach to AE Care for the Psychiatric Times Health Minute. They also discuss long term management strategies, including recognition of broad psychosocial ramifications as well as individual cognitive and psychiatric sequelae. https://www.psychiatrictimes.com/view/collaborating-best-outcomes-patients-autoimmune-encephalitis